Santen Pharmaceutical Co., Ltd.
4536.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥92,997 | ¥94,582 | ¥57,903 | ¥83,014 |
| Short-Term Investments | ¥997 | ¥379 | ¥774 | ¥1,293 |
| Receivables | ¥72,083 | ¥90,539 | ¥107,165 | ¥99,591 |
| Inventory | ¥51,590 | ¥43,185 | ¥39,352 | ¥37,141 |
| Other Curr. Assets | ¥7,630 | ¥7,454 | ¥8,132 | ¥8,387 |
| Total Curr. Assets | ¥224,300 | ¥236,139 | ¥213,326 | ¥229,426 |
| Property Plant & Equip (Net) | ¥72,954 | ¥71,576 | ¥66,173 | ¥56,287 |
| Goodwill | ¥8,242 | ¥8,303 | ¥7,385 | ¥13,715 |
| Intangibles | ¥67,225 | ¥75,516 | ¥88,924 | ¥116,502 |
| Long-Term Investments | ¥16,177 | ¥24,406 | ¥36,585 | ¥36,238 |
| Tax Assets | ¥10,017 | ¥10,765 | ¥2,810 | ¥3,103 |
| Other NC Assets | ¥10,362 | ¥8,994 | ¥5,976 | ¥4,706 |
| Total NC Assets | ¥184,977 | ¥199,560 | ¥207,853 | ¥230,551 |
| Other Assets | ¥0 | ¥0 | ¥0 | -¥1 |
| Total Assets | ¥409,277 | ¥435,699 | ¥421,179 | ¥459,976 |
| Liabilities | – | – | – | – |
| Payables | ¥38,989 | ¥24,042 | ¥25,282 | ¥24,420 |
| Short-Term Debt | ¥3,289 | ¥2,748 | ¥3,056 | ¥10,936 |
| Tax Payable | ¥0 | ¥5,127 | ¥6,745 | ¥4,198 |
| Deferred Revenue | ¥0 | ¥5,127 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥42,320 | ¥47,156 | ¥53,001 | ¥52,299 |
| Total Curr. Liab. | ¥86,837 | ¥92,796 | ¥89,504 | ¥95,821 |
| LT Debt | ¥26,483 | ¥27,463 | ¥28,198 | ¥12,677 |
| Deferred Rev, NC | ¥744 | ¥738 | -¥28,198 | ¥11,161 |
| Deferred Tax Liab, NC | ¥2,606 | ¥1,377 | ¥1,592 | ¥2,526 |
| Other NC Liab. | ¥2,969 | ¥3,009 | ¥29,509 | ¥0 |
| Total NC Liab. | ¥37,260 | ¥37,534 | ¥38,378 | ¥27,311 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥7,472 | ¥4,947 | ¥4,953 | ¥6,290 |
| Total Liabilities | ¥124,097 | ¥130,330 | ¥127,882 | ¥123,132 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥307,802 |
| Common Stock | ¥8,806 | ¥8,777 | ¥8,702 | ¥8,672 |
| Retained Earnings | ¥228,291 | ¥240,029 | ¥238,071 | ¥290,477 |
| AOCI | ¥40,509 | ¥48,413 | ¥37,781 | ¥29,686 |
| Other Equity | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥286,242 | ¥306,055 | ¥293,979 | ¥337,488 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -¥1,061 | -¥685 | -¥683 | -¥645 |
| Total Liab. & Tot. Equity | ¥409,277 | ¥435,699 | ¥421,861 | ¥460,620 |
| Net Debt | -¥63,225 | -¥64,371 | -¥26,649 | -¥59,401 |